-
Stuck Doing Math or Figuring Out Life's Numbers? Calculator.now Makes It Stupidly Simple
From monthly budgets to baby due dates, Calculator.now is helping people everywhere stop Googling formulas and just get the answer. Instantly. No signups, no fuss.. Read more
-
$18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
IQSTEL, Inc. (N A S D A Q: IQST) $IQST Investment Firm Litchfield Hills Research Issues Recommendation and Detailed Report on IQSTEL (IQST) with an $18 Price Target. Read more
-
AI Innovation Dual-Strategy Business Model Focused on Real Estate Development for Strategic Expansion: OFA Group, (N A S D A Q: OFAL)
OFA Group, (N A S D A Q: OFAL) $OFAL is Committed to Disciplined Capital Allocation, Executional Excellence and Pursuit of High-Impact Real Estate Opportunities.. Read more
-
$17.4 Million Total Revenue for First Half of 2025 (up 31.8% YOY) for Global Wet Trades Services Provider with High Value Bitcoin Investments
Ming Shing Group Holdings Limited, (N A S D A Q: MSW) $MSW Owns 833 Bitcoins with a Combined Investment of Approximately $74 million.. Read more
-
Plan to Launch Silo Technologies' Cybersecurity Pilot Program for Ultimate Nationwide Deployment via Exclusive Partnership: Stock Symbol: BULT
Bullet Blockchain, Inc. (Stock Symbol: BULT) $BULT Controls Ownership of Intellectual Property Portfolio That Includes Two Key Bitcoin ATM Patents. Read more
-
AI-Based Neurotoxin Countermeasure Initiative Launched to Address Emerging National Security Needs: Renovaro, Inc. (N A S D A Q: RENB)
Renovaro, Inc. (N A S D A Q: RENB) $RENB Also Receives U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform. Read more
-
$796,000 in Q2 Revenue Marks Highest Earnings to Date on 3 Trailing Quarters of Profitability in Multi-Billion Homebuilding Sector: Stock Symbol: IVDN
Innovative Designs (Stock Symbol: IVDN) $IVDN Super Small Share Structure with 38 Million OS / 17 Million Float and Record Sales Growth and Highest Profitability Level to Date for First 6 Months of 2025 With 265% Increase Year-Over-Year. Read more
-
Cybersecurity is THE Hot Market Sector; Revenues, Earnings & Profit matter; Only 33 Million Shares + a Huge Short Position Equal an Undervalued Stock
$69 Million in Recent Contract Awards for Innovative, Disruptive Cybersecurity Leader Cycurion Inc. (N A S D A Q: CYCU) $CYCU; 2025 Q1 Gross Profit and Serves Some of the Most Complex Government Agencies Including Fortune 100 and 500 Companies. Read more
-
Investor Spotlight: Cycurion, Inc. (N A S D A Q: CYCU) Secures $69M in Contracts Amid Surging Demand for AI-Powered Cybersecurity Solutions
Cycurion, Inc. (N A S D A Q: CYCU): $CYCU is a High-Growth Cybersecurity Leader Riding the AI Wave.. Read more
-
$328 Million Global Stroke Rehab Market Opportunity Awaits AI Telehealth Leader Following Selection for NIH Funded Phase 3 Clinical Study: VSee Health
VSee Health (N A S D A Q: VSEE) $VSEE Major Clients Include NASA, U.S. Department of Health and Human Services, McKesson, DaVita and the Entire Nation of Qatar. Read more
-
IQSTEL Surges Toward $400M Run Rate with $101.5M in Revenue—Reinforces Billion-Dollar Vision Backed by Fintech, AI, and Cybersecurity
IQSTEL Inc. (N A S D A Q: IQST) $IQST Driven by strong organic growth, high-margin expansion, and strategic acquisitions, IQST now forecasts hitting a $400 million annualized revenue run rate by year-end, as it races toward its $1 billion revenue goal by . Read more
-
Alpha Modus Files 7th IP Action Against Rackspace Following $3M CEO Investment and Strategic Partnership Expansion
(N A S D A Q: AMOD) $AMOD with Major IP Lawsuits, Strategic Partnerships, and a $3M CEO Investment, Alpha Modus Is Emerging as a Powerhouse in AI-Driven Retail Infrastructure. Read more
-
$750 Million Ketamine Drug Market Withing Reach via New Commissioner's National Priority Vouchers with Anticipated Approval by Year-End for NRx
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Has $7.8 Million for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD. Read more
-
Stalking Butler to revolutionize the trading industry
Follow. Learn. Earn. Follow your favorite hedge funds and portfolio managers and learn how to invest.. Read more
-
AI Meets Cybersecurity: IQSTEL and Cycurion Take Aim at $500 Billion Market Opportunity
Cycurion, Inc. (N A S D A Q: CYCU) and IQSTEL, Inc. (N A S D A Q: IQST) are leading the AI Telecom and Cybersecurity Charge.. Read more
-
Mauro Schnaidman named as Managing Director in Miami, Florida
MIAMI - -- STS Capital Partners is pleased to announce the appointment of Mauro Schnaidman as a Managing Director, based in Miami, Florida. He is a globally accomplished executive, M&A advisor, Board Member, and mentor with over 30 years of.... Read more
-
Vice President JD Vance & Industry Leaders at Bitcoin Conference After Partnership Signing to Optimize Cybersecurity Solutions: Bullet Blockchain, Inc
Bullet Blockchain, Inc. (Stock Symbol: BULT) $BULT Controls Ownership of Intellectual Property Portfolio That Includes Two Key Bitcoin & Crypto ATM Patents. Read more
-
Remember Internet Pioneers NetCom Solutions & Network Solutions? Founder Emmit J. McHenry is Now Leading the Emerging Cybersecurity Firm Cycurion
Cycurion (N A S D A Q: CYCU) $CYCU Cycurion, Inc. Serves Some of the Most Complex Government Agencies and Corporations, Including Fortune 100 and 500 Companies. Read more
-
$3.9M Q1 2025 Revenue Following $39M in Cybersecurity Contracts for Education and Transportation Sectors: Cycurion, Inc
Cycurion, Inc. (N A S D A Q: CYCU) $CYCU Reports 2025 Q1 Gross Profit of $677,673, Up 95.4% Year-Over-Year, with 17.5% Gross Margin Increase. Read more
-
$77.8 Million in Revenue Through April 2025, Confirms Full-Year Guidance; Fast-Track to 400 Million Run Rate; $1 Billion Target After Key Acquisition
IQSTEL, Inc. (Stock Symbol: IQST) $IQST Current Plans Include $1 Million Subsidiary Sale with Stock Dividend to Shareholders. Read more
-
$750 Million Market Projected to Reach $3.3 Billion Globally in 2034 for New Drug Application Filed on Preservative-Free IV Ketamine: NRx Pharma, Inc
NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Has $7.8 Million in Financing for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD. Read more
Your online source of trusted news